Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium carbonate for amyotrophic lateral sclerosis
ISRCTN83178718Phase 4Completed
- Sponsor
- King's College London
- Start
- May 2009
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
A Phase 4 trial of lithium carbonate in amyotrophic lateral sclerosis (ALS), sponsored by King's College London. Started May 2009; status: completed.
02
Drugs
lithium carbonate
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on ISRCTN83178718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN83178718.